183 related articles for article (PubMed ID: 9707506)
1. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
Santostefano MJ; Wang X; Richardson VM; Ross DG; DeVito MJ; Birnbaum LS
Toxicol Appl Pharmacol; 1998 Aug; 151(2):294-310. PubMed ID: 9707506
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
4. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2.
Mahajan SS; Rifkind AB
Toxicol Appl Pharmacol; 1999 Feb; 155(1):96-106. PubMed ID: 10036222
[TBL] [Abstract][Full Text] [Related]
6. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
[TBL] [Abstract][Full Text] [Related]
7. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
Santostefano MJ; Ross DG; Savas U; Jefcoate CR; Birnbaum LS
Biochem Biophys Res Commun; 1997 Apr; 233(1):20-4. PubMed ID: 9144388
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice.
Abdelhamid G; Amara IE; Anwar-Mohamed A; El-Kadi AO
Arch Toxicol; 2013 Aug; 87(8):1531-43. PubMed ID: 23423713
[TBL] [Abstract][Full Text] [Related]
9. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.
Wang X; Santostefano MJ; Evans MV; Richardson VM; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1997 Nov; 147(1):151-68. PubMed ID: 9356318
[TBL] [Abstract][Full Text] [Related]
10. Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17beta-estradiol in female Sprague-Dawley rats.
Badawi AF; Cavalieri EL; Rogan EG
Carcinogenesis; 2000 Aug; 21(8):1593-9. PubMed ID: 10910964
[TBL] [Abstract][Full Text] [Related]
11. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.
Andersen ME; Birnbaum LS; Barton HA; Eklund CR
Toxicol Appl Pharmacol; 1997 May; 144(1):145-55. PubMed ID: 9169078
[TBL] [Abstract][Full Text] [Related]
12. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
13. Expression of phase I and phase II genes in mouse embryonic stem cells cultured in the presence of 2,3,7,8-tetrachlorodibenzo-para-dioxin.
Neri T; Merico V; Garagna S; Redi CA; Zuccotti M
Biochim Biophys Acta; 2008 May; 1780(5):826-36. PubMed ID: 18334230
[TBL] [Abstract][Full Text] [Related]
14. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.
Walker NJ; Crofts FG; Li Y; Lax SF; Hayes CL; Strickland PT; Lucier GW; Sutter TR
Carcinogenesis; 1998 Mar; 19(3):395-402. PubMed ID: 9525272
[TBL] [Abstract][Full Text] [Related]
15. Physiological modeling of a proposed mechanism of enzyme induction by TCDD.
Kohn MC; Walker NJ; Kim AH; Portier CJ
Toxicology; 2001 May; 162(3):193-208. PubMed ID: 11369115
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent localization of TCDD in isolated centrilobular and periportal hepatocytes.
Santostefano MJ; Richardson VM; Walker NJ; Blanton J; Lindros KO; Lucier GW; Alcasey SK; Birnbaum LS
Toxicol Sci; 1999 Nov; 52(1):9-19. PubMed ID: 10568693
[TBL] [Abstract][Full Text] [Related]
17. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
18. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.
Emond C; Birnbaum LS; DeVito MJ
Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat.
Evans MV; Andersen ME
Toxicol Sci; 2000 Mar; 54(1):71-80. PubMed ID: 10746933
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
